FDMT logo
FDMT NASDAQ US

4D Molecular Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Dec 2020
$9.48
▼ $-0.39 (-3.95%)
Vol 707K
3
Quality Score
fail
Mkt Cap
$428.5M
ROE
-47.3%
Margin
-174314.2%
D/E
0.00
Beta
2.99
52W
$2–$12

Wall Street Consensus

17 analysts · Apr 2026
5
Strong Buy
9
Buy
3
Hold
0
Sell
0
Strong Sell
82.4%
Buy Rating

Price Chart

Similar Stocks

LRMR
Larimar Therapeutics Inc
$326.1M
TRDA
Entrada Therapeutics Inc
$392.9M
VSTM
Verastem Inc
$581.5M
LYEL
Lyell Immunopharma Inc
$653.9M
IMMX
Immix Biopharma Inc
$275.6M
ABSI
Absci Corp
$524.8M
ASMB
Assembly Biosciences Inc
$537.9M
STTK
Shattuck Labs Inc
$231.0M
MYGN
Myriad Genetics Inc
$573.3M

Earnings

Beat rate: 40.0%
Next Report May 06, 2026
EPS Estimate: $-1.02
Quarter EPS Est EPS Act Surprise
Mar 2026 $-1.02 — —
Dec 2025 $-0.78 $0.43 +$1.21
Sep 2025 $-1.00 $-1.01 $-0.01
Jun 2025 $-0.89 $-0.98 $-0.09

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -40.2% -40.2% -40.2% -40.2% -40.2% -47.3%
P/E (TTM) — — — — — —
Net Margin -364386.7% -594375.8% -594375.8% -594375.8% -594375.8% -174314.2%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 8.75 8.75 8.75 8.75 8.75 8.42

Key Ratios

ROA (TTM)
-42.4%
P/S (TTM)
3570.94
P/B
0.5
EPS (TTM)
$-3.74
CF/Share
$-2.52
Rev Growth 3Y
-87.3%
52W High
$12.34
52W Low
$2.24
$2.24 52-Week Range $12.34

How does FDMT compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

FDMT AAPG ABEO ABOS ABP

FDMT valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
3570.9
▲ 27689% above peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.5
▼ 80% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

FDMT profitability vs Biotechnology peers

ROE
-47.3%
▲ 30% above peers (-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-174314.2%
▼ 60690% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-42.4%
▲ 9% above peers (-46.7%)
vs Peers
vs Industry
In line

FDMT financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.4
▲ 90% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
3.0
▲ 208% above peers (1.0)
vs Peers
vs Industry
More volatile

FDMT fundamentals radar

FDMT Peer median Industry

FDMT profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

FDMT vs peers: key metrics

Latest News

No related news yet